A recent study indicates that patients who stop using blockbuster slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who stop traditional diet and exercise regimens.
Published data in a major health publication shows that while obese people often shed substantial amounts of their body weight while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.
"People buying such treatments must be informed of the risk of rapid weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.
That rate of recovery means a return to original weight within about 18 months.
Weighing Treatments
The analysis, which looked at dozens of trials involving thousands of participants, contrasted the effects of GLP-1 agonists with older methods.
Researchers emphasize that individuals who shed pounds through dieting generally have a more gradual weight regain—around 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Experts believe the way of the drugs is key to understanding the heightened rebound.
These medications copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal may cause the system to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating much more probable."
A Chronic Condition?
The NHS recommend the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
Professionals contend that, due to the likelihood of relapse, the treatment is often life-long.
This perspective is reinforced by drug manufacturers, who note that the findings "underscore the long-term character of excess weight," akin to managing diseases like diabetes.
Patient Experiences
People who have stopped the jabs report a sudden resurgence of hunger.
"It was like a switch that goes on and you're instantly starving," said a patient.
This difficulty is worsened if individuals have not adopted permanent dietary or behavioural modifications during treatment.
Widespread Interest
Figures suggest that millions of adults in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is more common among women than men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Finally, clinicians emphasize that while these medications are powerful agents for weight loss, they are not a magic fix and lasting health benefits likely depends on integrated lifestyle management.
